← Eichor
Condition: Nut Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Nut Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pe
Phase 1 · 7 location(s) · National Cancer Institute (NCI) · NCT05372640Biology of Young Lung Cancer Study: The YOUNG LUNG Study
Phase N/A · 4 location(s) · Dana-Farber Cancer Institute · NCT05265429A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Phase 1/Phase 2 · 6 location(s) · Tanabe Pharma America, Inc. · NCT06943521Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma
Phase 2 · 1 location(s) · Northwestern University · NCT07050186Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplat
Phase 1/Phase 2 · 5 location(s) · National Cancer Institute (NCI) · NCT05019716Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies
Phase 1 · 6 location(s) · Epigenetix, Inc. · NCT05488548
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.